SCHEMBL28003161

SCHEMBL28003161

COCC1COCCN1c1nc(OC)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 5/20 0.41
PDK1 Q15118 2/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
ATR Q13535 3/20 0.37
CHEK1 O14757 2/20 0.37
PDCD1 Q15116 2/20 0.37
ATRIP Q8WXE1 2/20 0.37
CD274 Q9NZQ7 2/20 0.37
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
PIK3CA P42336 4/20 0.33
PIK3CD O00329 2/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 2/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28003525 0.89 MTOR (0.39) MTORATRCHEK1PDCD1ATRIP
SCHEMBL3545517 0.86 PDK1 (0.39) MTORPDK1PDK2PDK3ALDH1A1
SCHEMBL3435190 0.84 MTOR (0.36) MTORPDK1PDK2PDK3ATR
SCHEMBL13634284 0.84 PDK1 (0.40) MTORPDK1PDK2PDK3ALDH1A1
SCHEMBL13634272 0.84 PDK1 (0.40) MTORPDK1PDK2PDK3ALDH1A1
SCHEMBL3551339 0.82 MTOR (0.37) MTORPDK1PDK2PDK3ALDH1A1
SCHEMBL28003505 0.82 ATR (0.46) MTORATRCHEK1PDCD1ATRIP
SCHEMBL3435910 0.81 PDK1 (0.38) MTORPDK1PDK2PDK3ALDH1A1
SCHEMBL13634351 0.81 PDK1 (0.38) MTORPDK1PDK2PDK3ALDH1A1
SCHEMBL28003498 0.81 ATR (0.36) MTORATRCHEK1PDCD1ATRIP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104583218-A Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation BRISTOL MYERS SQUIBB CO 2015-04-29 CN disclosed